BRPI0519930A2 - composição oral, e, método para inibir e/ou tratar uma condição inflamatória oral em um indivìduo mamìfero - Google Patents

composição oral, e, método para inibir e/ou tratar uma condição inflamatória oral em um indivìduo mamìfero

Info

Publication number
BRPI0519930A2
BRPI0519930A2 BRPI0519930-1A BRPI0519930A BRPI0519930A2 BR PI0519930 A2 BRPI0519930 A2 BR PI0519930A2 BR PI0519930 A BRPI0519930 A BR PI0519930A BR PI0519930 A2 BRPI0519930 A2 BR PI0519930A2
Authority
BR
Brazil
Prior art keywords
oral
inhibiting
treating
inflammatory condition
mammalian subject
Prior art date
Application number
BRPI0519930-1A
Other languages
English (en)
Inventor
Guofeng Xu
Zhigang Hao
David Viscio
Abdul Gaffar
Sarita V Mello
Michael Prencipe
Thomas J Boyd
Evangelia S Arvanitidou
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36215647&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0519930(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of BRPI0519930A2 publication Critical patent/BRPI0519930A2/pt
Publication of BRPI0519930B1 publication Critical patent/BRPI0519930B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8164—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers, e.g. poly (methyl vinyl ether-co-maleic anhydride)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

COMPOSIçãO ORAL, E, MéTODO PARA INIBIR E/OU TRATAR UMA CONDIçãO INFLAMATóRIA ORAL EM UM INDIVìDUO MAMìFERO. Composições para cuidado oral, contendo, um flavonóide de anel B livre e um flavano, assim como pelo menos um agente de melhora de biodisponibilidade, são providas. Os métodos de usar as composições orais são também providos.
BRPI0519930-1A 2004-12-22 2005-12-21 Composição oral, e, método para inibir e/ou tratar uma condição inflamatória oral em um indivíduo mamífero BRPI0519930B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US63933104P 2004-12-22 2004-12-22
US60/639,331 2004-12-22
US11/301,098 2005-12-12
US11/301,098 US20060140881A1 (en) 2004-12-22 2005-12-12 Oral care compositions containing flavonoids and flavans
PCT/US2005/046522 WO2006069210A2 (en) 2004-12-22 2005-12-21 Oral care compositions containing free-b-ring flavonoids and flavans

Publications (2)

Publication Number Publication Date
BRPI0519930A2 true BRPI0519930A2 (pt) 2009-09-08
BRPI0519930B1 BRPI0519930B1 (pt) 2015-06-23

Family

ID=36215647

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519930-1A BRPI0519930B1 (pt) 2004-12-22 2005-12-21 Composição oral, e, método para inibir e/ou tratar uma condição inflamatória oral em um indivíduo mamífero

Country Status (9)

Country Link
US (1) US20060140881A1 (pt)
EP (2) EP1827608A2 (pt)
AU (1) AU2005319184C1 (pt)
BR (1) BRPI0519930B1 (pt)
CA (1) CA2592283A1 (pt)
MX (1) MX2007007631A (pt)
RU (1) RU2393899C2 (pt)
SG (2) SG149857A1 (pt)
WO (1) WO2006069210A2 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
JP4723239B2 (ja) 2002-04-30 2011-07-13 ユニジェン・インコーポレーテッド 治療剤としての遊離−ｂ−環フラボノイド類とフラバン類との混合物の製剤
US8945518B2 (en) 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
AU2004228021B2 (en) 2003-04-04 2010-09-02 Unigen, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
US20070140990A1 (en) 2005-12-21 2007-06-21 Nataly Fetissova Oral Compositions Comprising Propolis
GB0614353D0 (en) * 2006-07-20 2006-08-30 Oraldent Ltd Oral compositions, their preparation and use
US20100008869A1 (en) * 2006-07-21 2010-01-14 Kao Corporation Method for preventing coloration of catechins and dentifrice composition
BRPI0700927B8 (pt) * 2007-03-16 2021-05-25 Oligo Basics Agroindustrial Ltda composição antimicrobiana
JP2010540647A (ja) 2007-10-01 2010-12-24 コルゲート・パーモリブ・カンパニー 植物性抽出物を含有する口腔組成物
US8986659B2 (en) * 2007-11-16 2015-03-24 Wam Oral Care Products, LLC Diamond, precious and semi-precious dust polishing agent for dental veneers and teeth
BRPI0906452A2 (pt) 2008-02-08 2015-07-14 Colgate Palmolive Co Composição, dispositivo, método para produzir ou inibir a formação de cáries dentais, reduzir, reparar ou inibir as leões pré-cárie do esmalte, reduzir ou inibir a desmineralização e promover a remineralização dos dentes, reduzir a hipersensibilidade dos dentes, reduzir ou inibir a gengivite, promover a cura de feridas ou de cortes na boca, reduzir os níveis de bactérias que produzem ácido, aumentar os níveis relativos de bactérias arginolíticas, inibir a formação de composição, dispositivo, método para reduzir ou inibir a formação de cáries dentais, reduzir, reparar ou inibir as leões pré-cárie dp esmalte, reduzir ou inibir a desmineralização e promover a remineralização dos dentes, reduzir a hipersibilidade dos dentes, reduzir ou inibir a gengivite, promover a cura de feridas ou de cortes na boca, reduzir os níveis de bactérias que produzem ácido, aumentar os níveis relativos de bactérias arginolíticas, inibir a formação de biofilme microbiano na cavidade oral, elevar e/ou manter o ph da placa em níveis de pelos menos um ph de 5,5, reduzir o acúmulo de placa, tratar, aliviar ou reduzir a boca seca, limpar os dentes e a cavidade oral, reduzir a erosão, branquear os dentes, imunizar os dentes contra as bactérias cariogênicas, e/ ou promover a saúde sistêmica, incluindo a saúde cardiovascular, e, uso de um aminoácido básico
PL2254591T3 (pl) * 2008-02-08 2018-01-31 Prothera Inc Inhibicja i leczenie biofilmów żołądkowo-jelitowych
DE102008011691A1 (de) 2008-02-28 2009-09-10 Schülke & Mayr GmbH Stabilisierte, antimikrobiell wirksame Zusammensetzung mit einem Gehalt an Bispyridiniumalkan
CA2780756A1 (en) * 2009-11-23 2011-05-26 Prothera, Inc. Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
BR112012013329A2 (pt) 2009-12-04 2016-03-01 Colgate Palmolive Co composição oral e método para o tratamento de uma doença ou condição do tecido mole da cavidade oral
MY152711A (en) 2009-12-04 2014-11-28 Colgate Palmolive Co Oral compositions containing a combination of natural extracts and related methods
WO2011068814A1 (en) 2009-12-04 2011-06-09 Colgate-Palmolive Company Oral compositions containing extracts of garcinia mangostana l. and related methods
BR112012013473A2 (pt) 2009-12-04 2016-05-17 Colgate Palmolive Co composição para higiene oral e método para o tratamento de uma doença ou condição do tecido mole da cavidade oral
BR112012013193A2 (pt) 2009-12-04 2016-03-01 Colgate Palmolive Co composição oral contendo zizyphus joazeiro e métodos relacionados
GB2481630A (en) * 2010-07-01 2012-01-04 Robert Taylor Composition for dental health
KR101804718B1 (ko) 2010-08-07 2017-12-05 더 리서치 파운데이션 포 더 스테이트 유니버시티 오브 뉴욕 아연 화합물 및 항-미생물제를 포함하는 구강용 조성물
JP6203469B2 (ja) * 2011-06-03 2017-09-27 花王株式会社 歯磨組成物
BR112013032266A2 (pt) 2011-06-17 2016-09-06 Unilever Nv composição de cuidado bucal e uso de sal de zinco selecionado
WO2013092117A2 (en) 2011-12-20 2013-06-27 Unilever N.V. An oral care composition
US10064907B2 (en) 2012-02-23 2018-09-04 Oligo Basics Agroindustrial Ltda. Process to improve feed efficiency and carcass characteristics of animals
US10123953B2 (en) 2012-06-21 2018-11-13 The Procter & Gamble Company Reduction of tooth staining derived from cationic antimicrobials
RU2494725C1 (ru) * 2012-08-20 2013-10-10 Общество С Ограниченной Ответственностью "Сплат-Косметика" (Ооо "Сплат-Косметика") Минерально-ферментативный комплекс для укрепления и отбеливания эмали зубов, композиция для гигиены полости рта и зубная паста
WO2014033314A1 (en) 2012-09-03 2014-03-06 Uab Bioseka Antisense oligonucleotide targeting bacterial glucosyltransferases
MX352553B (es) * 2012-12-17 2017-11-29 Colgate Palmolive Co Composicion para el cuidado oral comprendiendo un compuesto de amadori.
ES2593618T3 (es) * 2012-12-18 2016-12-12 Sunstar Suisse Sa Composición oral tópica para aliviar los síntomas de la boca seca y para el tratamiento de úlceras bucales
US10195124B2 (en) * 2012-12-24 2019-02-05 Colgate-Palmolive Company Oral care composition
US9656102B2 (en) * 2013-04-23 2017-05-23 Rita Vaccaro Thin film toothpaste strip
US10105296B2 (en) 2013-04-23 2018-10-23 Rita Vaccaro Thin film toothpaste strip
AR106776A1 (es) * 2015-12-01 2018-02-14 Colgate Palmolive Co Composiciones de cuidado oral
EP3664796A4 (en) 2017-08-13 2021-05-12 Buzzelet Development And Technologies Ltd TERPENE-ENRICHED CANNABINOID COMPOSITION AND TREATMENT PROCESS
CN113164337A (zh) * 2018-12-04 2021-07-23 宝洁公司 具有改善的锡相容性的口腔护理组合物

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE192346C (pt) *
JPS5311314B2 (pt) * 1974-09-25 1978-04-20
US4277595A (en) * 1979-09-13 1981-07-07 Bausch & Lomb Incorporated Water absorbing contact lenses made from polysiloxane/acrylic acid polymer
US4276402A (en) * 1979-09-13 1981-06-30 Bausch & Lomb Incorporated Polysiloxane/acrylic acid/polcyclic esters of methacrylic acid polymer contact lens
JPS59152311A (ja) * 1983-02-18 1984-08-31 Sunstar Inc 口腔用組成物
US4816245A (en) * 1983-12-28 1989-03-28 Colgate-Palmolive Company Antiplaque/antigingivitis method using certain polyphosphonic acids
JPS61268259A (ja) * 1985-05-24 1986-11-27 ライオン株式会社 消臭剤
JPH0755895B2 (ja) * 1985-08-29 1995-06-14 サンスター株式会社 歯磨組成物
US5180578A (en) * 1987-01-30 1993-01-19 Colgate-Palmolive Company Antibacterial antiplaque anticalculus oral composition
US4894220A (en) * 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US5288480A (en) * 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
US5080887A (en) * 1987-01-30 1992-01-14 Colgate-Palmolive Company Antibacterial antiplaque, anticalculus oral composition
US5344641A (en) * 1987-01-30 1994-09-06 Colgate-Palmolive Co. Antibacterial antiplaque oral composition
ES2053962T3 (es) * 1988-11-28 1994-08-01 Unilever Nv Dentrificos conteniendo amino alquil siliconas.
US5334375A (en) * 1988-12-29 1994-08-02 Colgate Palmolive Company Antibacterial antiplaque oral composition
US5234688A (en) * 1988-12-29 1993-08-10 Colgate-Palmolive Company Anti-plaque dentifrice packaged in resilient squeezable form maintaining dispensing container
IL92693A0 (en) * 1989-08-25 1990-09-17 Colgate Palmolive Co Antibacterial antiplaque composition containing novel styrene-phosphonic acid copolymer
GB8922594D0 (en) * 1989-10-06 1989-11-22 Unilever Plc Oral compositions
EP0499015A1 (en) * 1991-02-15 1992-08-19 Fockerman, Jasmine Benzopyran phenol derivates for use as antibacterial, antiviral or immunostimulating agents
KR940006065B1 (ko) * 1991-06-27 1994-07-06 주식회사 태평양 충치 및 치주질환에 유효한 치약 조성물
US5236699A (en) * 1992-06-22 1993-08-17 Libin Barry M Antiplaque mouth rinse
US5888491A (en) * 1993-12-06 1999-03-30 Minnesota Mining And Manufacturing Company Optionally crosslinkable coatings, compositions and methods of use
JPH07242555A (ja) * 1994-03-08 1995-09-19 Suntory Ltd グルコシルトランスフェラーゼ阻害剤およびこれを有効成分として含有する抗う蝕剤並びに抗う蝕性食品
US5681548A (en) * 1994-07-15 1997-10-28 Colgate Palmolive Company Oral formulations
US5651959A (en) * 1995-06-05 1997-07-29 Whitehill Oral Technologies, Inc. Ultramulsion based oral care compositions
US5723500A (en) * 1995-09-22 1998-03-03 Colgate-Palmolive Company Antiplaque oral composition and method
US5912274A (en) * 1995-09-22 1999-06-15 Colgate-Palmolive Company Antiplaque oral composition and method
US6602526B2 (en) * 1996-02-23 2003-08-05 Medical Doctors Research Institute Oral compositions containing lotus
US5741138A (en) * 1996-08-12 1998-04-21 The Procter & Gamble Company Oral compositions
US20030206874A1 (en) * 1996-11-21 2003-11-06 The Proctor & Gamble Company Promoting whole body health
US6190644B1 (en) * 1996-11-21 2001-02-20 The Procter & Gamble Company Dentifrice compositions containing polyphosphate and monofluorophosphate
CA2235655C (en) * 1997-04-24 2008-01-22 Sunstar Inc. Oral compositions comprising porous calcium carbonate
US5874068A (en) * 1997-12-08 1999-02-23 Warner-Lambert Company Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts
US6241975B1 (en) * 1999-07-24 2001-06-05 Pacific Corporation Method for preparation of plant extract powder
US6117415A (en) * 1999-06-17 2000-09-12 Alpharx Inc. Toothpaste comprising bioadhesive submicron emulsion for improved delivery of antibacterial and anticaries agents
US6290933B1 (en) * 2000-05-09 2001-09-18 Colgate-Palmolive Company High cleaning dentifrice
US6403059B1 (en) * 2000-08-18 2002-06-11 J. M. Huber Corporation Methods of making dentifrice compositions and products thereof
US6685921B2 (en) * 2000-10-25 2004-02-03 The Procter & Gamble Company Dental care compositions
CA2431044A1 (en) * 2000-12-13 2002-06-20 University Of Rochester Oral compositions and use thereof
CN1193734C (zh) * 2000-12-20 2005-03-23 艾茗 防龋消炎口服液
US6514484B2 (en) * 2001-03-19 2003-02-04 The Procter & Gamble Company Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier
US6565300B2 (en) 2001-07-26 2003-05-20 Mitchell D. Herring Tie down assembly attachment method for straightening and reinforcing pickup truck bed walls
US6696047B2 (en) * 2001-09-13 2004-02-24 The Procter & Gamble Company Stable oral care compositions comprising chlorite
US20040057908A1 (en) * 2001-12-13 2004-03-25 Bowen William H. Oral compositions and use thereof
US7972632B2 (en) * 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US20030165588A1 (en) * 2002-03-01 2003-09-04 Unigen Pharmaceuticals, Inc. Identification of free-B-ring flavonoids as potent COX-2 inhibitors
JP4723239B2 (ja) * 2002-04-30 2011-07-13 ユニジェン・インコーポレーテッド 治療剤としての遊離−ｂ−環フラボノイド類とフラバン類との混合物の製剤
JP2004083443A (ja) * 2002-08-23 2004-03-18 Hideji Watanabe マスティックを用いた歯周病予防・治療用組成物及び歯周病予防・治療方法
US6692726B1 (en) * 2003-02-11 2004-02-17 Colgate Palmolive Company Enzyme containing oral composition having enhanced stability
AU2004228021B2 (en) 2003-04-04 2010-09-02 Unigen, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
WO2005017177A2 (en) * 2003-05-14 2005-02-24 The Regents Of The University Of The Michigan Modulators of nod1 signaling
JP2004352621A (ja) * 2003-05-27 2004-12-16 Inabata Koryo Kk 消臭剤及び該消臭剤を含有する口腔用組成物、食品組成物並びに消臭剤組成物
EP1663126A1 (de) * 2003-09-09 2006-06-07 DSM IP Assets B.V. Oral wirkendes im wesentlichen wasserfreies topisches mittel enthaltend ein oder mehrere oxidationsempfindliche stoffe
US20050226947A1 (en) * 2004-02-04 2005-10-13 Dale Kern Agents for sequestering serum aging factors and uses therefore
TW200630102A (en) * 2004-10-19 2006-09-01 Unigen Pharmaceuticals Inc Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
US8119169B2 (en) * 2004-12-28 2012-02-21 Colgate-Palmolive Company Oregano oral care compositions and methods of use thereof
US20060140885A1 (en) * 2004-12-29 2006-06-29 Abdul Gaffar Method of reducing oral tissue inflammation using magnolia extract
CN101262796B (zh) * 2005-07-12 2011-11-16 高露洁-棕榄公司 用于分发活性剂的具有储罐的口腔护理器具

Also Published As

Publication number Publication date
SG149869A1 (en) 2009-02-27
WO2006069210A3 (en) 2006-11-09
WO2006069210A2 (en) 2006-06-29
EP2308565A2 (en) 2011-04-13
SG149857A1 (en) 2009-02-27
MX2007007631A (es) 2007-08-03
AU2005319184A1 (en) 2006-06-29
CA2592283A1 (en) 2006-06-29
BRPI0519930B1 (pt) 2015-06-23
RU2007128038A (ru) 2009-01-27
RU2393899C2 (ru) 2010-07-10
US20060140881A1 (en) 2006-06-29
AU2005319184B2 (en) 2011-10-06
EP1827608A2 (en) 2007-09-05
EP2308565A3 (en) 2016-02-10
AU2005319184C1 (en) 2012-05-10

Similar Documents

Publication Publication Date Title
BRPI0519930A2 (pt) composição oral, e, método para inibir e/ou tratar uma condição inflamatória oral em um indivìduo mamìfero
UY27729A1 (es) Inhibidores de quinasas.
DK1494692T3 (da) Topiske, farmaceutiske sammensætninger, der omfatter proanthocyanidiner, glycyrrhetinsyre og telmestein til behandlingen af dermatitis
BRPI0509172A (pt) pelo menos uma entidade quìmica, composição farmacêutica, métodos para tratar um paciente, para inibir pelo menos uma enzima que utiliza atp, e para tratar pelo menos uma doença, uso de pelo menos uma entidade quìmica, e, método para a fabricação de um medicamento
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
TW200730518A (en) Crystalline forms of docetaxel and processes for their preparation
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
BRPI0520539A2 (pt) composições minimizadoras de cachos queratina protetora, método e kit para tal
MXPA05013977A (es) Metodos y composiciones para tratar enfermedades relacionadas con amiloide.
BRPI0414908A (pt) compostos de benzazóis substituìdos, composições e métodos de inibição da atividade raf quinase em um humano ou animal
BRPI0511139A (pt) compostos, composição farmacêutica que compreende os mesmos, método para inibir atividade de quinase aurora em uma célula e método para tratamento de um distúrbio mediado por quinase aurora em um paciente
TW200603798A (en) Disalt inhibitors of il-12 production
ATE378337T1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
DK1761266T3 (da) Forbindelser, formuleringer og fremgangsmåder til at behandle eller forebygge inflammatoriske hudsygdomme
DK1651161T3 (da) Farmaceutiske præparater og fremgangsmåder til at fremme sårheling
UA86591C2 (ru) Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
ATE425982T1 (de) Thienopyrimidin-derivate als kaliumkanal- inhibitoren
MX2009003022A (es) Composiciones y metodos para tratar picaduras de medusa.
DE602004029376D1 (de) Fettzusammensetzung für backware, sowie backware
ATE530547T1 (de) Derivate und analoge von chroman als funktionell selektive alpha2c-adrenorezeptor-agonisten
EA200801211A1 (ru) Производные 9-хлор-15-простагландина, способ их получения и использования в лекарственных препаратах
UA107177C2 (uk) Імуногенна композиція цвс2 та спосіб приготування такої композиції
SE0300457D0 (sv) Novel compounds
TW200637596A (en) Oral care compositions containing flavonoids and flavans

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO EM SUA FORMA AUTENTICADA; OU SEGUNDO PARECER DA PROCURADORIA NO 074/93, DEVE CONSTAR UMA DECLARACAO DE VERACIDADE, A QUAL DEVE SER ASSINADA POR UMA PESSOA DEVIDAMENTE AUTORIZADA A REPRESENTAR O INTERESSADO, DEVENDO A MESMA CONSTAR NO INSTRUMENTO DE PROCURACAO, OU NO SEU SUBSTABELECIMENTO.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/12/2005, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 11A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)